Among the many cybersecurity and privacy risks involving the fast evolving global coronavirus outbreak are potential concerns related to the development of vaccines, says public health risk management expert Stanley Mierzwa of Kean University in Union, New Jersey.
“In my experience … there are activities that take place where one is required in the interest of security and monitoring to introduce something called a ‘site monitor,'” Mierzwa says in an interview with Information Security Media Group.
During clinical trials and research on vaccines or treatments for diseases, such as Covid-19, an individual site monitor or team of monitors typically goes to the site to ensure adherence to standard operating procedures involving technology or the trial procedures, he says.
“There are many, many subtasks that are included in this work – technology as well as items related to security have to take place,” he says. “With the emergence of coronavirus, it’s possible here that there will be less site monitoring visits … performed to … evaluate proper cybersecurity and technology operations,” he…
